About
BioNTech is a next-generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. It contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates.
Position in the VCSift Database
- • 4,609 investors in VCSift focus on the biotech sector.
- • 16 investors are based in Mainz, Rheinland-Pfalz, Germany.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- biotech
- Location
- Mainz, Germany
Contact Information
Find more investors like BioNTech
Search Investors